| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $18.2M | -15.2% | -14.3% |
| SG&A Expense | $6.9M | -3.1% | +18.3% |
| Operating Income | -$25.1M | +12.2% | +7.3% |
| Income Tax | $0 | — | — |
| Net Income | -$20.1M | +20.5% | +13.0% |
| EPS (Basic) | -$0.32 | +34.7% | +33.3% |
| EPS (Diluted) | -$0.32 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.7M | -14.8% | +1.1% |
| Short-term Investments | $375.8M | +1.3% | +96.6% |
| Current Assets | $482.7M | -2.6% | +62.5% |
| Total Assets | $490.9M | -2.6% | +60.7% |
| Current Liabilities | $14.7M | -3.7% | -14.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$54.5M | — | — |
| Investing Cash Flow | -$186.2M | — | — |
| Financing Cash Flow | $218.2M | — | — |
| +33.3% |
| $14.8M |
| -4.3% |
| -13.4% |
| Stockholders' Equity | $476.1M | -2.5% | +65.1% |